500mg PO BID
eGFR 0 - 10eGFR 10 - 50eGFR > 50500mg PO daily500mg PO q12-24h500mg PO q12h
500mg PO daily
Dose after dialysis on HD days
CAP
Pertussis
URTI
H. pylorI and mycobacterial infections
Monitor QTc in patients with increased risk
Neutropenia
GI upset
Prolongation of QTc interval
Drug interactions
Recommend review of patient medications due to high frequency of significant interactions
CYP450 interactions ++
Other QTc prolonging agents
Statins - increased rhabdo
CCBs - hypotension, AKI
Colchicine - increased bone marrow toxicity
Increased anticonvulsant levels
Increased tacrolimus levels
EH Prescribing Restrictions None
Non-XL Tablets can be crushed for NG administration; Liquid formulation also available
OPEN BENEFIT No prescribing restrictions
Antimicrobial class: Macrolide
Pregnancy category: C
Average serum half life: 5 hours
Biliary penetration: Therapeutic
CSF penetration: Poor
Lung penetration: Therapeutic
Urine penetration: Poor